Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
GSK (2)
60 Articles Available
2
3
Can't find what you're looking for? Try our
advanced search
.
Announcement
GSK Announces Positive Headline Results from the Pivotal DREAMM-2 Study for Multiple Myeloma
PR-M08-19-NI-075
HIV Treatment
ViiV Healthcare Reports Positive Phase III Study Results of Investigational, Long-acting, Injectable HIV-treatment Regimen Administered Every Two Months
PR-M08-19-NI-074
Asthma
Asthma Patients in Europe Will Have Access to a Self-Administered Syringe
PAO-M08-19-NI-031
Leadership
GSK Announces Leadership Changes in the US
PR-M08-19-NI-047
Drug Discovery
Heart-on-a-Chip Mimics Drug Response Seen in Humans: In Vitro Approach Provides Predictive Platform for Human-Based Drug Discovery
PR-M08-19-NI-045
Leadership
GSK Grows Oncology Pipeline Under CSO’s Leadership
PAO-M08-19-NI-018
M&A
GSK Completes Transaction with Pfizer to Form New Consumer Healthcare Joint Venture
PR-M08-19-NI-009
MorphoSys Gets Milestone Payment from GSK for Otilimab
Influenza
GSK Ships 2019-20 Seasonal Influenza Vaccines for US Market
PR-M07-19-NI-047
Phase III
GSK Announces Positive Headline Results in Phase 3 PRIMA Study of ZEJULA (niraparib) For Patients with Ovarian Cancer
PR-M07-19-NI-039
ViiV Healthcare Announces Phase III Study Meets Primary Endpoint
PR-M07-19-NI-032
Genomic Research
GSK Joins Forces with the University of California to Advance Genomic Research and Improve Drug Discovery
PR-M06-19-NI-018
Announcement
GSK Announces Changes to Their Sales Representative Incentive Program
PR-M05-19-NI-083
M&A
Thermo Fisher Scientific to Acquire Manufacturing Site in Cork, Ireland, from GSK
PR-M05-19-NI-051
Asthma
GSK Has Hopes for Trelegy in Asthma
PAO-M05-19-NI-011
Consumer Healthcare
GSK and Pfizer’s Combined Consumer Healthcare Business Will Focus on the U.S. and China
PAO-M04-19-NI-016
Drug Development
New Blood Cancer Drug Shows Promise
PAO-M03-19-NI-039
Acquisition
GSK Acquires Oncology Company Tesaro
PAO-M12-18-NI-008
Acquisition
Unilever’s Indian Subsidiary to Acquire GSK’s Consumer Nutrition Brands in India
PAO-M12-18-NI-002
New Facility
GSK Opens New Facility in Scotland
PAO-M11-18-NI-007
FDA Approval
GSK’s ViiV Healthcare Seeks FDA Approval for Combination HIV Therapy
PAO-M10-18-NI-029
Investment
GSK Funds British Biotech Sitryx
PAO-M10-18-NI-011
Vaccine
Promising Phase 2b Results for New GSK Tuberculosis Vaccine
PAO-M10-18-NI-002
FDA
FDA Committee Gives Nod to New Treatment for Plasmodium Vivax Malaria
PAO-M07-18-NI-010
«
2
3
»
.svg)
